Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995502004> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2995502004 endingPage "374" @default.
- W2995502004 startingPage "365" @default.
- W2995502004 abstract "The effects of acarbose and sitagliptin on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus (T2DM) were studied. One hundred and three patients with poorly controlled T2DM with insulin aspart 30 were selected and randomly divided into three groups: group A [continuous subcutaneous insulin infusion (CSII) treatment group], group B (CSII combined with acarbose treatment), group C (CSII combined with sitagliptin treatment). The treatment lasted for two weeks and the clinical indicators in the three groups were measured. The insulin dosage was adjusted according to the blood glucose statuses of the three groups of patients. In the final three days, 72 h of continuous glucose monitoring (CGM) were carried out, and the OGTT test was performed again. The results showed that the MODD (absolute means of daily difference), intra-day blood glucose fluctuation indices [(24 h MBG (mean blood glucose), LAGE (largest amplitude of glycemic excursions) and MAGE (average blood glucose fluctuation)] and postprandial blood glucose fluctuation indices [PGS (postprandial glucose spike), △t, PPGE (postprandial glucose excursion) and T (time) total] in group C and group B were significantly lower than those in group A. Compared with group B, the difference in blood glucose fluctuation indices in group C was not statistically significant (P>0.05). The HOMA-islet (homeostasis model assessment of islet) (CP-DM) index and FC-P (Fasting c-peptide) levels in group C and group B were significantly higher than those in group A (P less than 0.01). The HOMA-IR (CP) index of groups B and C was significantly lower than that of group A (P less than 0.01), and there was no statistically significant difference between groups B and C (P less than 0.05). Sitagliptin combined with intensive insulin pump therapy can reduce blood glucose fluctuation throughout the day, reduce insulin dosage, improve islet B cell function and reduce hypoglycemia better than intensive insulin pump therapy alone." @default.
- W2995502004 created "2019-12-26" @default.
- W2995502004 creator A5017654199 @default.
- W2995502004 creator A5030766162 @default.
- W2995502004 creator A5056763455 @default.
- W2995502004 creator A5056843491 @default.
- W2995502004 creator A5079026542 @default.
- W2995502004 date "2019-04-12" @default.
- W2995502004 modified "2023-09-27" @default.
- W2995502004 title "Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus." @default.
- W2995502004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30972995" @default.
- W2995502004 hasPublicationYear "2019" @default.
- W2995502004 type Work @default.
- W2995502004 sameAs 2995502004 @default.
- W2995502004 citedByCount "4" @default.
- W2995502004 countsByYear W29955020042021 @default.
- W2995502004 countsByYear W29955020042022 @default.
- W2995502004 countsByYear W29955020042023 @default.
- W2995502004 crossrefType "journal-article" @default.
- W2995502004 hasAuthorship W2995502004A5017654199 @default.
- W2995502004 hasAuthorship W2995502004A5030766162 @default.
- W2995502004 hasAuthorship W2995502004A5056763455 @default.
- W2995502004 hasAuthorship W2995502004A5056843491 @default.
- W2995502004 hasAuthorship W2995502004A5079026542 @default.
- W2995502004 hasConcept C126322002 @default.
- W2995502004 hasConcept C134018914 @default.
- W2995502004 hasConcept C165220095 @default.
- W2995502004 hasConcept C2776617576 @default.
- W2995502004 hasConcept C2777391703 @default.
- W2995502004 hasConcept C2778199505 @default.
- W2995502004 hasConcept C2779284873 @default.
- W2995502004 hasConcept C2779306644 @default.
- W2995502004 hasConcept C2780473172 @default.
- W2995502004 hasConcept C2910068830 @default.
- W2995502004 hasConcept C3018667095 @default.
- W2995502004 hasConcept C555293320 @default.
- W2995502004 hasConcept C71924100 @default.
- W2995502004 hasConceptScore W2995502004C126322002 @default.
- W2995502004 hasConceptScore W2995502004C134018914 @default.
- W2995502004 hasConceptScore W2995502004C165220095 @default.
- W2995502004 hasConceptScore W2995502004C2776617576 @default.
- W2995502004 hasConceptScore W2995502004C2777391703 @default.
- W2995502004 hasConceptScore W2995502004C2778199505 @default.
- W2995502004 hasConceptScore W2995502004C2779284873 @default.
- W2995502004 hasConceptScore W2995502004C2779306644 @default.
- W2995502004 hasConceptScore W2995502004C2780473172 @default.
- W2995502004 hasConceptScore W2995502004C2910068830 @default.
- W2995502004 hasConceptScore W2995502004C3018667095 @default.
- W2995502004 hasConceptScore W2995502004C555293320 @default.
- W2995502004 hasConceptScore W2995502004C71924100 @default.
- W2995502004 hasIssue "2" @default.
- W2995502004 hasLocation W29955020041 @default.
- W2995502004 hasOpenAccess W2995502004 @default.
- W2995502004 hasPrimaryLocation W29955020041 @default.
- W2995502004 hasRelatedWork W2029148695 @default.
- W2995502004 hasRelatedWork W2080135029 @default.
- W2995502004 hasRelatedWork W2091673245 @default.
- W2995502004 hasRelatedWork W2094616918 @default.
- W2995502004 hasRelatedWork W2129737421 @default.
- W2995502004 hasRelatedWork W2144804229 @default.
- W2995502004 hasRelatedWork W2153745306 @default.
- W2995502004 hasRelatedWork W2419476943 @default.
- W2995502004 hasRelatedWork W2995502004 @default.
- W2995502004 hasRelatedWork W817185891 @default.
- W2995502004 hasVolume "33" @default.
- W2995502004 isParatext "false" @default.
- W2995502004 isRetracted "false" @default.
- W2995502004 magId "2995502004" @default.
- W2995502004 workType "article" @default.